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Abstract
Cash payments to improve health outcomes have been used for many years, however, their use for
HIV prevention is new and the impact not yet well understood. We provide a brief background on
the rationale behind using cash to improve health outcomes, review current studies completed or
underway using cash for prevention of sexual transmission of HIV, and outline some key
considerations on the use of cash payments to prevent HIV infections. We searched the literature
for studies that implemented cash transfer programs and measured HIV or HIV-related outcomes.
We identified 16 studies meeting our criteria; 10 are completed. The majority of studies have been
conducted with adolescents in developing countries and payments are focused on addressing
structural risk factors such as poverty. Most have seen reductions in sexual behavior and one large
trial has documented a difference in HIV prevalence between young women getting cash transfers
and those not. Cash transfer programs focused on changing risky sexual behaviors to reduce HIV
risk suggest promise. The context in which programs are situated, the purpose of the cash transfer,
and the population will all affect the impact of such programs; ongoing RCTs with HIV incidence
endpoints will shed more light on the efficacy of cash payments as strategy for HIV prevention.
Background
Thirty years into the global HIV epidemic, effective methods to prevent new HIV infections
remain limited to biomedical interventions. Recently, several effective, new interventions,
including male circumcision, oral and vaginal pre-exposure prophylaxis, and treatment as
prevention have emerged.1–5 If taken to scale, these interventions have the potential to
significantly reduce the number of new infections globally; however, there are numerous
barriers to the widespread uptake and impact of these interventions which include economic,
behavioral, structural and biological factors.6–9 At the structural level, barriers to successful
implementation of biomedical interventions may include financial barriers to individual
uptake or to government ability to offer interventions, lack of skilled personnel to offer new
interventions, and/or cultural norms that are not supportive of the behaviors required for
uptake or use of interventions. Effective combination prevention approaches will require
interventions that address structural and behavioral risk factors to have a maximum impact
on the epidemic.
Recently, the use of cash payments to reduce HIV risk, either by addressing structural risk
factors such as poverty or by incentivizing behavior change, has emerged as a novel
prevention tool receiving significant attention.10–12 While the use of cash to improve health
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outcomes has a long history in development, social protections, and psychology (e.g.
contingency management), less is known about its potential impact on HIV prevention. We
provide a brief background on the rationale behind using cash as a means to improve health
outcomes, review current studies that have been completed or are underway using cash for
HIV prevention, and outline some key considerations with regard to the use of cash
payments as a means to prevent new HIV infections.
Historical Overview
Programs that use cash payments to improve individual well-being have been in existence
for a number of decades. Some of the first programs using cash to improve health outcomes
come from the development and social protection fields where cash transfers have
traditionally been implemented to alleviate the impact of poverty.13 Cash transfer programs
are currently estimated to reach over 1 billion people in the developing world.14 These
payments have been both unconditional (payments normally go to households deemed
‘poor’ but individuals are not required to do anything to receive payments) and conditional
(payments are tied to behaviors deemed beneficial to the individual). It is theorized that
providing cash to poor households improves health outcomes by making health care, food,
or education more affordable by increasing household income.14 Such programs have aimed
to increase uptake of prevention health services (e.g. antenatal care services,
immunizations), and to improve growth outcomes, primarily in children. Overall these
programs have been effective in increasing the use of preventive health services although the
evidence on improving health outcomes is mixed. 15,16
Behavioral economists also theorize that improving recipients’ socio-economic status and
access to better food and educational opportunities can affect recipients’ expectations of
their life expectancy, outlook for the future, and preferences for ‘healthier behaviors.13
Further, they hypothesize that cash transfers conditioned on investments in social goods
such as education and health may offset myopia whereby individuals may invest more in
goods or services with immediate rewards rather than those where benefits may only vest in
the future, such as education.13,14 Building on behavioral economic theory, lessons learned
from research on incentives and health suggest include findings that small, tangible
incentives provided frequently and close to the observed outcome are more effective than
larger payments made less often.17
Psychologists have also used cash to improve health outcomes through contingency
management (CM). Such interventions are based on the theory that behaviors targeted for
change should be monitored frequently and rewarded with tangible incentives when desired
behavior change is demonstrated.18 Contingency management strategies have been used to
address a number of unhealthy behaviors for the past 30–40 years, including smoking
cessation19, obesity management20, and most commonly substance abuse21–23, and have
shown varying levels of success. Lessons learned from CM interventions are similar to those
from the behavioral economics literature and also emphasize the importance of measuring
readily detectible target behaviors, and providing tangible incentives when desired behaviors
are demonstrated and withholding when behaviors not demonstrated.24 Some other
strategies used in CM found to be effective for controlling substance abuse include
escalating incentives that reset to zero when the desired behavior is not achieved and the use
of lottery or “fish-bowl” drawing based rewards.25 The efficacy of such methods has yet to
be tested in the HIV prevention field.
Methods
To provide a comprehensive summary of the evidence regarding cash for HIV prevention,
we aimed to review all studies that have been completed or are underway that use cash or
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financial incentives and measure HIV or HIV-related outcomes. We included studies which
aim to reduce the risk of sexual transmission of HIV by either providing participants with
cash transfers (both conditional and unconditional); providing incentives for particular risk
reduction outcomes; or reducing financial barriers to schooling. Schooling is the focus of
many cash transfer programs due to the numerous benefits found to be associated with
increased years of schooling, in particular among women. Women with more education have
been found to be at lower risk of HIV infection, have fewer children, and have greater
earning potential.26 We identified studies for inclusion in multiple ways: to identify
completed studies, we searched the PubMed and EconLit databases using search terms (cash
transfer, cash incentive, cash reward, monetary reward, economic assets, contingency
management, or school fee) and (HIV, STD, STI, pregnancy, or sexual behavior); to identify
unpublished studies and studies currently underway, we also searched the websites of The
World Bank, the NIH Research Portfolio Online Reporting Tool, archived abstracts from
AIDS and APHA conferences (2000–2011), and relied on personal communications. From
each of the studies identified, we abstracted information about the target population (age,
sex), the study (design, sample size, location), the intervention (transfer type,
conditionality), and the major results, if available.
Results
Review of the evidence
As of April 2012, we identified 16 studies that aimed to reduce HIV risk with cash transfers,
providing incentives for particular risk reduction outcomes, or reducing financial barriers to
schooling (Table 1). Nine of the studies were completed in the last seven years, six are
underway, and one was completed more than twenty years ago. We posit that these
interventions fall into one of two categories with regard to their mechanism of action: 1)
interventions that provide cash to address up-stream structural risk factors for HIV (e.g.
payments to relieve poverty or increase education) and are thus more directly related to
development/social protection programs or 2) interventions that provide cash incentives for
immediate measureable outcomes related to HIV (e.g. cash for HIV tests or negative HIV or
STD test results) and are thus most similar to contingency management. The majority of
studies fall into category 1: that is, they aim to address larger structural barriers to HIV
prevention by reducing poverty or alleviating economic barriers to schooling. Two studies,
CAPRISA 007 and Yo Puedo, fall into both categories, as they aim to address structural risk
factors through cash transfers for school-related activities, while also providing cash rewards
for specific outcomes such as HIV testing or negative pregnancy tests.27,28 The majority of
the studies are conducted in developing countries (14/16) and focus on adolescents (15/16).
Nine studies provide cash on a conditional basis, six provide cash on an unconditional basis,
and one examines the effect of both. The purpose of the transfer varies by study (and
conditionality or not), but include: school attendance, school completion, poverty
alleviation, and completion of health promotion activities, such as STI/HIV testing. The
majority of studies are randomized controlled trials (15/16) and thus controlled for
confounding in the study design. The only observational study controlled for appropriate
factors at a range of levels.29 Studies measure a variety of outcomes, including sexual
behaviors and intentions (12/16), STI status (2/16), and HIV status (5/16). Overall, the
majority of studies that have measured a change in sexual behaviors found a positive impact
(9/10); however, one pilot study found a negative impact in men (Malawi Incentives
Project): immediately after receiving their cash incentive, men reported more sex acts
(although they also reported more condom use).30 Only one large RCT, the SIHR trial, has
released results on HIV outcomes. At the 18-month follow up, the study found lower HIV
prevalence among the intervention participants compared to the controls.31 Three large
RCTs are currently underway among adolescents in South Africa (CAPRISA 007 and
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HPTN 068) and Tanzania (Iringa Combination HIV Prevention Trial) to determine the
impact of cash transfers on HIV incidence 27,32,33.
Discussion
Programmatic considerations of cash payment interventions
Despite the promise of interventions that provide cash to reduce HIV risk, it is not clear that
there is a one-size-fits-all cash payment intervention or whether such interventions will be
effective in reducing HIV infection across populations. To date only one study has found a
decrease in HIV prevalence related to cash payments (primarily because few studies to date
have had biological endpoints), although the vast majority of studies have found positive
impacts on sexual behaviors.
The mechanism whereby cash reduces risk depends heavily on the target population and
how cash may (or may not) influence HIV risk factors for that population. Thus, how a cash
payment intervention should be structured—whether it should be conditioned and on what,
the frequency of payments, the amount of the payment, and to whom it is made—depends
heavily on these factors. For example, conditioning payments on school attendance may
only be relevant in settings where there are financial barriers to schooling and where
schooling appears to be protective against HIV. Formative research on incentives for HIV
prevention conducted in Malawi has confirmed theory from behavioral economics and
contingency management that smaller payments made more frequently and closer to the
behavior being observed are more effective than larger payments in the future.24,34
As we describe, there are two main types of cash/incentive for behavior change, one that
aims to address upstream drivers of risk, such as poverty and education, and the other that
provides cash for the downstream behavior change itself. The majority of studies aim to
address upstream, structural barriers that increase HIV risk such as education or poverty.
These studies hypothesize that improving the socio-economic situation of vulnerable
populations or providing cash payments conditioned on social goods, such as school
attendance, will reduce HIV risk (category 1 interventions). Other studies hypothesize that
providing cash for specific outcomes like a negative STI test will serve as an incentive for
individuals not to engage in high risk behavior (category 2 interventions). However, it is
unclear whether interventions premised on rewarding specific HIV-related outcomes
actually address factors that place individuals at risk. While there is the assumption that cash
payments will serve as motivation for HIV/STI reduction behaviors, there is some evidence
that the relationship between cash incentives and behavior might be more complex. The
Malawi Incentives Project found payments for negative HIV tests increased risk in men,
suggesting that giving cash to individuals may have unintended consequences.30
The amount of the payment likely will matter in determining whether behavior change
occurs or not. It is still unclear what payment amount is necessary for desired behavior
change and how the type (cash vs. in-kind payment) and frequency of payment influence
outcomes. Research conducted in Malawi to date suggests that even a small incentive can
encourage uptake of interventions and behavior change; however, the applicability of these
findings to wealthier and more urban settings is unknown. At the end of the day what
matters is which intervention type is more effective in preventing new infections—likely
this will not be black and white and different designs may work differently for different
populations. This complexity speaks to the importance of formative and ethnographic
research and pilot studies in potential study populations to understand pathways that lead to
risk and how cash transfers or incentives might best be structured to reduce risk.
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Who gets the payment also likely matters with regard to cash payments. For young women
who are at high risk of HIV infection in sub-Saharan Africa, recent evidence from the SIHR
trial suggests that addressing structural factors by providing cash to young women reduces
their risk.31 It appears that providing young women with access to their own income was
important in reducing HIV risk, as it enabled them to make safer choices in sex partners—
young women who received cash irrespective of whether or not it was conditional, were less
likely to have older partners or exchange sex for money. Many existing cash transfer
programs do not provide cash payments to minors; rather the parent/guardian receives the
payment. Given the potential impact on HIV and sexual behavior of direct payment to
adolescents, the results of the CAPRISA 007 and HPTN 068 studies, which provide cash
payments to adolescents, may have implications for future recipients of cash transfer
programs.
While some cash transfer interventions do not address up-stream factors that affect HIV risk
(category 2 interventions), in the new prevention landscape, there are circumstances where
these interventions may play a significant role. Treatment as prevention,5 Pre-exposure
Prophylaxis (PrEP),1,4 and Prevention of Mother to Child Transmission35 all require
individuals to test for HIV as a necessary first step. Cash incentives may be one way to
increase testing numbers. Evidence from Malawi suggests that cash incentives are effective
in encouraging individuals to receive their HIV test results.36 Adherence to drugs is also a
critical component of the efficacy of these interventions; studies have been conducted
looking at the role of contingency management in improving ART adherence, including
HPTN 065/TLC PLUS,37 which is currently testing the impact of using cash transfers for
HIV-related health visits and adherence to ART.38–40 Clearly, there are important behavioral
and structural barriers to individuals testing for HIV or to adhering to medication that need
to be addressed; cash incentive programs may not address these factors but may still have an
impact on behavior.
While providing cash to individuals is hypothesized to reduce risk, concerns have been
raised that individuals receiving the cash could be placed at risk for negative outcomes such
as violence, bullying, coercion, or using the cash for high-risk activities. Similar concerns
were raised when government social welfare programs provided payments to female instead
of male heads of households. Concerns were raised that women would suffer negative
consequences as a result of receiving the payment, however, to date, the evidence shows that
payments made to female heads of have not resulted in increased intimate partner violence.
In fact, women are the more effective beneficiaries with regard to multiple health and
education outcomes compared to men.41,42 Though there is no evidence to date of social
harm to individuals as a result of providing cash transfers, existing programs should
carefully monitor changes in intergenerational and gender relationships for such events.
Infusing cash into communities can create complex dynamics; thus, the need for
transparency about selection criteria and intended purpose for receiving the cash is
paramount.
Conclusion
Preliminary data from cash payment interventions to reduce HIV risk suggest that they
might be effective, particularly among young women. As always, concerns over scalability
come into play with implementing cash transfer programs. However, with large social
welfare programs in place in many countries, including those hard hit by the HIV epidemic,
if cash payment programs are found to be effective these programs could be tailored to
address scale up and cost of implementation. Ongoing research from randomized controlled
studies will provide information on whether cash payment programs are a cost-effective
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strategy for preventing new HIV infections and what role they may play in the larger
prevention agenda.
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